IOVA
NASDAQ · Biotechnology
Iovance Biotherapeutics Inc
$8.04
+0.30 (+3.88%)
Performance
1D
+0.00%
1W
+0.25%
1M
-39.59%
3M
+25.63%
6M
+117.30%
1Y
+249.57%
YTD
+219.05%
Open$8.10
Previous Close$7.74
Day High$8.28
Day Low$7.72
52W High$15.37
52W Low$1.76
Volume—
Avg Volume20.08M
Market Cap3.62B
P/E Ratio—
EPS$-0.72
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$11.38
Below
SMA 200
$5.98
Above
RSI (14)
23.7
Oversold
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
16 analysts
Price Target
+581.2% upside
Current
$8.04
$8.04
Target
$54.77
$54.77
$41.45
$54.77 avg
$77.23
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 331.94M | 337.04M | 333.93M |
| Net Income | -492,513,973 | 23.64M | 18.09M |
| Profit Margin | -148.4% | 7.0% | 5.4% |
| EBITDA | -462,848,795 | 42.24M | 40.52M |
| Free Cash Flow | — | 21.56M | 19.96M |
| Rev Growth | — | +17.4% | +6.9% |
| Debt/Equity | 0.00 | 0.20 | 0.17 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |